Filing metadata

Accession number
0001606074-19-000014
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Jun 26, 2019
Reporting period
Jun 24, 2019
Description
Insider transaction

Explore SEC Filings Hub